# KRAZATI
> **NDA216340** · New Drug Application · Sponsor: BRISTOL · Approved 2022-12-12
## Drug
- **FDA Application Number:** NDA216340
- **Application type:** New Drug Application
- **Brand name:** KRAZATI
- **Generic name:** ADAGRASIB
- **Active ingredients:** ADAGRASIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL
- **Manufacturer:** Mirati Therapeutics, Inc
- **First approval:** 2022-12-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216340)
---
*MORVS · CC0 1.0*